Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115139) titled 'Research on Stratified Intervention and adjuvant Therapy for Schizophrenia Based on Niacin Metabolism' on Dec. 23, 2025.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Shanghai Jiao Tong University
Condition:
Schizophrenia
Intervention:
Niacin Invention:Nicotinic acid tablet supplement
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-01-01
Target Sample Size: Niacin Invention:75;Placebo:75;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=294963
Published by HT Digital Content Services with perm...